Abstracts tagged "patient preferences"

Abstract Number: 2249 • 2019 ACR/ARP Annual Meeting
Evaluation of Rheumatoid Arthritis Patients’ Preferences Using Discrete Choice Experiment
Aniket Kawatkar¹, ¹Kaiser Permanente Southern California, Pasadena, CA
Background/Purpose: Rheumatoid arthritis (RA) exerts multifaceted burden through medical expenditures, productivity losses, disability, and intangible costs of pain, fatigue, and loss of functional capacity. Patient…
Abstract Number: 2251 • 2019 ACR/ARP Annual Meeting
Understanding Vulnerabilities in Diagnosis and Care of Childhood and Adult-Onset Lupus: A Qualitative Study
Siobhan Case¹, Corine Sinnette ², Courtnie Phillip ², Claire Grosgogeat ³, Karen Costenbader ², Cianna Leatherwood ⁴, Candace Feldman ² and Mary Beth Son ³, ¹Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³Boston Children's Hospital, Boston, MA, ⁴Kaiser Permanente, San Francisco, CA
Background/Purpose: Systemic lupus erythematosus (SLE) poses complex diagnostic and management challenges, which may differ depending on whether SLE was diagnosed in childhood (cSLE) or in…
Abstract Number: 2254 • 2019 ACR/ARP Annual Meeting
The Urge for Mobile Apps in Rheumatology – a German Patient Perspective
Johannes Knitza¹, Christina Raab ¹, Antonia Lambrecht ¹, David Simon ², Melanie Hagen ¹, Sara Bayat ¹, Georg Schett ³, Arnd Kleyer ¹ and Axel Hueber ⁴, ¹Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, ²Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, ³Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, ⁴Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; Sektion Rheumatologie, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany, Erlangen, Germany
Background/Purpose: Mobile health applications have the potential of saving costs, empowering patients and improving treatment outcomes. Furthermore, the use of medical apps in routine care…
Abstract Number: 2366 • 2018 ACR/ARHP Annual Meeting
Facilitating Shared Decision Making in Psoriatic Arthritis: Factors Influencing Patient Preference for Treatment Mode of Administration
Daniel Aletaha¹, M. Elaine Husni², Joseph F. Merola³, Roberto Ranza⁴, Heidi Bertheussen⁵, Ralph Lippe⁶, Pamela Young⁷, Joseph C Cappelleri⁸, T Michelle Brown⁹, Claire Ervin⁹, Ming-Ann Hsu⁸ and Lara Fallon¹⁰, ¹Medical University of Vienna, Vienna, Austria, ²Cleveland Clinic, Orthopedic and Rheumatologic Institute, Cleveland, OH, ³Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁴Servicio de Reumatología, Universidade Federal de Uberlandia, Santa Mônica, Uberlândia, Brazil, ⁵Patient Representative, Oslo, Norway, ⁶Pfizer Pharma GmbH, Berlin, Germany, ⁷Pfizer Inc, Collegeville, PA, ⁸Pfizer Inc, Groton, CT, ⁹RTI Health Solutions, Research Triangle Park, NC, ¹⁰Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Shared decision making is key to optimizing management of patients (pts) with psoriatic arthritis (PsA).1 Few studies have evaluated pt preferences for treatment administration…
Abstract Number: 2368 • 2018 ACR/ARHP Annual Meeting
Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand¹, Maysoon Eldoma¹, Deborah A. Marshall² and Glen Hazlewood^1,3, ¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Community Health Sciences, University of Calgary, Calgary, AB, Canada, ³Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada
Background/Purpose: Treatment choices in rheumatoid arthritis (RA) involve trade-offs in risks, benefits and other considerations such as dosing. Understanding patient preferences for these trade-offs is…
Abstract Number: 2370 • 2018 ACR/ARHP Annual Meeting
Physician and Patient Preferences for Treating SLE: Insights into the Choice of Intravenous Infusion and Subcutaneous Injection
Matthew Lau¹, Christopher F Bell¹, Christine Poulos² and Ameya Benegal³, ¹GlaxoSmithKline, Research Triangle Park, NC, ²RTI Health Solutions, Research Triangle Park, NC, ³RTI Health Solutions, RTP, NC
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by diverse clinical manifestations, chronic inflammation, and significant morbidity that can be fatal1.…
Abstract Number: 2372 • 2018 ACR/ARHP Annual Meeting
Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases – Results of a Global Survey
Paul Studenic¹, Alessia Alunno², Simon R Stones³, Valentin Ritschl⁴ and Elena Nikiphorou⁵, ¹Division of Rheumatology, Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ²Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, ³School of Healthcare, University of Leeds, Leeds, United Kingdom, ⁴Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University of Vienna, Vienna, Austria, Vienna, Austria, ⁵Academic Rheumatology, Department of Inflammation Biology, King's College London, London, Great Britain
Background/Purpose: Smartphone applications and social media (SM) are increasingly used, transforming the way in which people communicate. Peer interaction, remote information access and community building…
Abstract Number: 1394 • 2018 ACR/ARHP Annual Meeting
Development and Pilot of a Patient Satisfaction Scale in Rheumatology
Antonia Valenzuela¹, Khushboo Sheth², Stanford Shoor², Philip L. Ritter² and Kate Lorig³, ¹Immunology and Rheumatology, Stanford University, Palo Alto, CA, ²Immunology & Rheumatology, Stanford University, Palo Alto, CA, ³Stanford University, Palo Alto, CA
Background/Purpose: Patient satisfaction has been studied as a performance improvement measure in clinical practice among patients with a variety of diseases, but to date there…
Abstract Number: 2343 • 2018 ACR/ARHP Annual Meeting
Exploring Decision Making Needs about Pain Management Among Adolescents with Juvenile Idiopathic Arthritis and Their Families: Preliminary Results from Interviews
Karine Toupin-April¹, Jennifer N. Stinson², Adam Huber^3,4, Ciarán M. Duffy⁵, Isabelle Gaboury⁶, Esi Morgan^7,8, Lucie Brosseau⁹, William Brinkman^7,8, Linda Li¹⁰, Tania El Hindi¹¹, Aditi Sivakumar¹¹, Marg Bisch¹², Janice Cohen¹³, Elizabeth Stringer¹⁴, France Légaré¹⁵, Laurie Proulx¹⁶, Paul R. Fortin¹⁷ and Peter Tugwell¹⁸, ¹Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ²Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, ³IWK Health Centre, Halifax, NS, Canada, ⁴Dalhousie University, Halifax, NS, Canada, ⁵Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁶Universite de Sherbrooke, Sherbrooke, ON, Canada, ⁷Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸University of Cincinnati, Cincinnati, OH, ⁹University of Ottawa, Ottawa, ON, Canada, ¹⁰Arthritis Research Canada, Richmond, BC, Canada, ¹¹Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ¹²Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, ¹³Children's Hospital of Eastern Ontario Research Institute, ottawa, ON, Canada, ¹⁴Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, ¹⁵Laval University, Montreal, QC, Canada, ¹⁶Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ¹⁷Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada, ¹⁸Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada
Background/Purpose: Adolescents with juvenile idiopathic arthritis (JIA), one of the most common causes of chronic musculoskeletal pain among youth, face many difficult decisions. However, we…
Abstract Number: 2344 • 2018 ACR/ARHP Annual Meeting
Treatment Modes in Rheumatoid Arthritis: Moving Toward Shared Decision-Making
Peter C. Taylor¹, Neil Betteridge², T Michelle Brown³, John Woolcott⁴, Alan J. Kivitz⁵, Cristiano A F Zerbini⁶, Diane Whalley⁷, Oyebimpe Olayinka-Amao³, Connie Chen⁸, Palle Dahl⁹, Dario Ponce de Leon¹⁰, David Gruben¹¹ and Lara Fallon¹², ¹University of Oxford, Oxford, United Kingdom, ²Neil Betteridge Associates, London, United Kingdom, ³RTI Health Solutions, Research Triangle Park, NC, ⁴Pfizer Inc, Collegeville, PA, ⁵Altoona Center for Clinical Research, Duncansville, PA, ⁶Centro Paulista de Investigação Clinica, São Paulo, Brazil, ⁷RTI Health Solutions, Manchester, United Kingdom, ⁸Pfizer Inc, New York, NY, ⁹Pfizer Inc, Ballerup, Denmark, ¹⁰Pfizer Inc, Lima, Peru, ¹¹Pfizer Inc, Groton, CT, ¹²Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Treatment recommendations in RA emphasize shared decision-making,1 but little is known about patient (pt) perspectives. Through qualitative research, we aim to understand pt preferences…
Abstract Number: 2351 • 2018 ACR/ARHP Annual Meeting
Attitudes Toward Telehealth Video Conferencing Among Patients with Rheumatic Disease
Dawen Zhang^1,2, Jennifer Lu², Cleopatra Aquino- Beaton², Nancy Harada² and Meika A. Fang^1,2, ¹UCLA Dept of Medicine, Division of Rheumatology, Los Angeles, CA, ²VA Greater Los Angeles Healthcare System, Los Angeles, CA
Background/Purpose: Video Teleconferencing (VTC) telehealth is a synchronous medium in which patients may interact with physicians using their own personal electronic device or at a…
Abstract Number: 358 • 2017 ACR/ARHP Annual Meeting
Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis
M. Elaine Husni^1,2, Anthony Fernandez¹, Rakesh Singh³, Brett Hauber⁴, Jessie Sutphin⁴, Joshua Posner⁴ and Arijit Ganguli³, ¹Cleveland Clinic, Cleveland, OH, ²Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, ³AbbVie Inc., North Chicago, IL, ⁴RTI Health Solutions, Research Triangle Park, NC
Background/Purpose: Psoriasis and psoriatic arthritis arise from the same immune system response but result in different symptoms and impacts on daily activities. A patient with…
Abstract Number: 1252 • 2017 ACR/ARHP Annual Meeting
Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis
Kaleb Michaud^1,2, Rebecca Schumacher², Bernard Vrijens³, Eric Tousset³, Gorana Dasic⁴, Connie Chen⁴, Ekta Agarwal⁴ and Maria Suarez-Almazor⁵, ¹University of Nebraska Medical Center, Omaha, NE, ²National Data Bank for Rheumatic Diseases, Wichita, KS, ³WestRock Healthcare, Visé, Belgium, ⁴Pfizer Inc, New York, NY, ⁵Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX
Background/Purpose: While weekly methotrexate (MTX) remains the gold standard treatment for patients with RA, studies suggest that MTX adherence may be sub-optimal and could be…
Abstract Number: 1856 • 2017 ACR/ARHP Annual Meeting
Patient and Physician Perspectives on Content Value for Educational Material Regarding Rare Rheumatic Diseases
Chris Hatzis¹, Elizabeth Soto-Cardona², Jessica K. Gordon² and Robert F. Spiera², ¹Medicine, Hospital for Special Surgery, New York, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Internet-based information is important for patients and their caregivers. For the past 4 years, our academic medical center’s Center for Scleroderma, Vasculitis & Myositis…
Abstract Number: 2782 • 2017 ACR/ARHP Annual Meeting
Patient Beliefs and Preference to Initiate a Proposed Medication in Rheumatoid Arthritis
Richard W Martin¹, Rohit Nallani², Andrew D Head¹, Aaron T Eggebeen¹, James D Birmingham¹ and Eric T Slavin¹, ¹Medicine, Rheumatology, Michigan State University, College of Human Medicine, Grand Rapids, MI, ²Michigan State University, College of Human Medicine, Grand Rapids, MI
Background/Purpose : Normative economic theory assumes that people making decisions have complete information of the options, rationally weigh the opportunity costs, expected outcomes and optimize…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].